A data-driven analysis of the fastest-growing therapeutic segments in India - perfect insights for PCD franchise partners planning their product portfolio.
India Evolving Healthcare Needs
India pharmaceutical market is shaped by changing demographics, lifestyle diseases, and improving healthcare access. Understanding which therapeutic segments are growing fastest helps franchise partners and pharma entrepreneurs make informed portfolio decisions.
1. Cardiac & Diabetic
With over 100 million diabetic patients and increasing cardiovascular disease incidence, this segment continues to lead with double-digit annual growth. Key products: antihypertensives, statins, anti-diabetic combinations.
2. Gastroenterology
Lifestyle changes have made acid peptic disorders extremely common. PPIs (Pantoprazole, Rabeprazole), antacids, and probiotics show consistent demand.
3. Anti-Infectives
Despite antibiotic stewardship efforts, anti-infectives remain a high-volume segment. Cephalosporins, macrolides, and amoxiclav combinations are mainstays.
4. Respiratory
Air pollution and rising allergies drive growth. Bronchodilators, mucolytics, and cough preparations maintain strong demand year-round, especially in winter.
5. Pediatric
India population of 0-14 year olds drives this segment. Pediatric syrups, drops, and ORS are essential portfolio items.
6. Dermatology
Rising aesthetic awareness and skin conditions like acne, eczema, fungal infections fuel growth. Combination creams (steroid + antibiotic + antifungal) are particularly popular.
7. Gynaecology
Iron supplements, calcium preparations, and women-specific hormonal therapies show steady growth driven by maternal health initiatives.
8. Orthopedic
Aging population and lifestyle-related joint problems sustain demand for analgesics, calcium supplements, and arthritis medications.
9. Nutraceuticals
Post-pandemic awareness of immunity and nutrition has made nutraceuticals (multivitamins, protein supplements) the fastest-growing segment.
10. Neuro & Psychiatry
Reducing stigma and increased awareness drive growth in anxiolytics, antidepressants, and neuropathic pain medications.
Portfolio Strategy for Franchise Partners
A balanced PCD franchise portfolio should include products from at least 6-8 segments to ensure consistent revenue and reduce dependency on any single category. Cardiac-Diabetic, GI, and Anti-infectives typically form the revenue backbone, while Pediatric and Nutraceuticals provide consistent monthly orders. At Calyra Life Sciences, we offer products across all 12 major therapeutic segments — making us a one-stop partner for pharmaceutical entrepreneurs across India.